ccRCC is the most common type of kidney cancer, making up to 80% of all renal cell carcinoma cases in adults. Estimating the prognosis is critical for patient management, but
is still a very challenging task. The ongoing research on this topic has led to the creation of two public studies:CPTAC-CCRCC and TCGA-KIRC, from which we curated MMIST-ccRCC.
Number of modalities across the Dataset
|
Patients |
CT |
MRI |
WSI |
Genomics |
Clinical |
| Train |
497 |
189 |
35 |
497 |
361 |
497 |
| Test |
121 |
59 |
13 |
121 |
101 |
121 |
| Total |
618 |
248 |
48 |
618 |
462 |
618 |
Lung cancer remains one of the most prevalent and lethal malignancies.
The MMIST Lung Dataset is a curated multi-center, multi-modal, and
longitudinal dataset comprising 1,365 lung cancer patients, including
1,026 patients from TCGA and 339 patients from CPTAC.
The dataset was curated from CPTAC-LSCC, CPTAC-LUAD,
TCGA-LUSC, and TCGA-LUAD, covering both lung squamous cell
carcinoma (LUSC/LSCC) and lung adenocarcinoma (LUAD).
It integrates clinical data, transcriptomic profiles, whole-slide
images (WSI), CT and PET scans, as well as longitudinal follow-up
and treatment information.
Distribution of patients per modality in the Dataset
| Modality |
Patients |
Missingness |
Alive @12 months |
Deceased @12 months |
| Clinical |
1365 |
0% |
1169 (86%) |
196 (14%) |
| Transcriptomics |
1284 |
6% |
1107 (86%) |
177 (14%) |
| Follow-up |
880 |
35% |
777 (88%) |
103 (12%) |
| Chemotherapy |
277 |
80% |
245 (88%) |
32 (12%) |
| Radiation Therapy |
923 |
32% |
804 (87%) |
119 (13%) |
| Surgery |
291 |
79% |
250 (86%) |
41 (14%) |
| Immunotherapy |
49 |
96% |
45 (92%) |
4 (8%) |
| WSI |
1359 |
0.4% |
1164 (86%) |
195 (14%) |
| CT |
71 |
95% |
58 (82%) |
13 (18%) |
| PET |
33 |
98% |
26 (79%) |
7 (21%) |
